Skip to main content
See every side of every news story
Published • loading... • Updated

New Drug Candidate ERAS 0015 Overcomes Historical Barriers in Targeting RAS Gene Mutations

AURORAS-1 investigators reported tumors shrank in 11 of 25 previously treated pancreatic cancer patients at 32 milligrams; larger trials must confirm safety.

  • On Friday, Erasca presented early-stage trial results for ERAS-0015, an experimental pill that shrank tumors in patients with advanced lung and pancreatic cancer at the 38th EORTC-NCI-AACR Symposium in Barcelona.
  • ERAS-0015 acts as a 'molecular glue' that blocks faulty RAS proteins, effectively shutting down vital signals cancer cells need to grow and multiply. This targets tumors driven by RAS mutations, previously thought impossible to drug.
  • Tumors shrank in 44% of 25 previously treated pancreatic cancer patients receiving 32 mg, while 60% of five lung cancer patients who had received prior immunotherapy also responded to the treatment.
  • Medical Oncologist Dr. Judy Wang, Florida Cancer Specialists and Research Institute, stated the findings demonstrate 'clinically meaningful activity' for patients with few options. Twelve patients reported severe treatment-related side effects.
  • Erasca plans to start late-stage clinical trials in 2027 to confirm safety and efficacy in pancreatic and lung cancers, also testing ERAS-0015 alongside the experimental treatment ERAS-4001.
Insights by Ground AI

11 Articles

informacion.esinformacion.es
+3 Reposted by 3 other sources
Center

The results of the phase I AURORAS-1 clinical trial of a cancer drug called ERAS-0015, have shown that it is safe and has managed to reduce the size of lung and pancreas tumors. Obtained in 148 patients "are important because ERAS-0015 acts on tumors whose growth is driven by mutations of the RAS gene (a family of genes that regulates cell growth and division). Until recently it was considered impossible to design drugs capable of acting effecti…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal